It’s been about a month since my last buy, dividends kept coming in and I managed to scrape some additional fresh capital together to initiate a position in Gilead. This biotech company is trading very closely to its 52 week low, it has a yield of 2.19 percent and a very low payout ratio of around 15 percent as it’s trading at a P/E of just 7.36
I picked up 10 GILD shares. After taxes this adds $11.66 in yearly dividend income, bringing my 12-month forward looking dividend projection to 1257.47EUR at today’s currency exchange rates. I’m in the early stages of writing a more detailed article about this company, perhaps it will be online next week.
Dividends are Coming 
Is that the company behind the famous blue medicine?
LikeLike
The famous blue pill is made by Pfizer. Gilead is primarily HIV and Hepatitis C treatment, I think the blue pill in the photo is Truvada (HIV treatment).
LikeLike
hmmm…. 2 diseases with a future… I will read with great interest your analyses when it is online
LikeLike
Great buy. GILD is a great company with a fantastic pipeline. And it’s undervalued. Nice purchase.
LikeLiked by 1 person
Thanks for your comment IH. I may pick up more shares if they’re still trading around this range next month.
LikeLike